Tafinlar Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

tafinlar

novartis europharm limited - dabrafenib mesilate - melanoma - Æxlishemjandi lyf - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 og 5. viðbótar meðferð melanomadabrafenib ásamt trametinib er ætlað til viðbótar meðferð fullorðinn sjúklinga með stigi iii húðkrabbanum með meÐferÐ v600 stökkbreyting, eftir fylltu brottnám. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.

Abstral Tungurótartafla 400 míkróg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

abstral tungurótartafla 400 míkróg

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 400 míkróg